Directors' Dealings

RNS Number : 1637R

Accrol Group Holdings PLC

12 June 2018

 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

12 June 2018

                                                                              Accrol Group Holdings plc

(AIM: ACRL) 

Directors' Dealings

Accrol Group Holdings plc (the "Company" or "Accrol"), the AIM-listed leading independent tissue converter, is pleased to announce that, as part of the recent open offer announced on 7 June 2018, certain directors of Accrol have purchased in aggregate 81,807 ordinary shares of £0.001 each ("Ordinary Shares") at a price of 15p per Ordinary Share as set out below.

		Number of Shares	Value of Shares	Resulting Shareholding	Percentage of Enlarged Share Capital
Name	Title
Daniel Wright	Executive Chairman	71,807	£10,771.05	1,820,308	0.93%
Gareth Jenkins	Chief Executive Officer	10,000	£1,500.00	610,000	0.31%

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	i)             Dan Wright ii)            Gareth Jenkins
2	Reason for the notification
a)	Position/status	i)            Executive Chairman ii)           Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Accrol Group Holdings plc
b)	LEI	213800MC56M5G69RJ226
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of £0.001 ISIN: GB00BZ6VT592
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	Price(s) 15p	Volume(s) i) 71,807 ii) 10,000
d)	Aggregated information - Aggregated volume - Price	N/A - single transaction
e)	Date of the transaction	8 June 2017
f)	Place of the transaction	London Stock Exchange, AIM

Enquiries:

For further information, please contact:
Accrol Group Holdings plc
Gareth Jenkins, Chief Executive Officer	[phone]
Steve Townsley, Chief Finance Officer	[phone]
Zeus Capital Limited (Nominated Adviser & Broker)
Dan Bate / Andrew Jones	[phone]
Dominic King / John Goold	[phone]
Belvedere Communications Limited
Cat Valentine ([e-mail])	[phone]
Llew Angus ([e-mail])	[phone]

Notes to Editors

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. 

Accrol operates from three sites:

·      A manufacturing, storage and distribution facility in Blackburn;

·      A facial tissue plant, also in Blackburn; and

·      A manufacturing, storage and distribution facility in Leyland.

 

END

 

 

DSHDMGMVDZKGRZM